You are here

Chi Med

Four biotech Nasdaq wannabes outline IPO plans — and don't miss Chi-Med's HKEX pitch

Endpoints

Mon, 04/15/19 - 12:11 pm

Applied Therapeutics

Milestone Pharmaceuticals

Chi-Med, Innovent enter global cancer partnership

BioCentury

Sat, 12/1/18 - 12:01 pm

Innovent Biologics